ZeroStack Corp

zerostack.ai

What Do They Do?

Manages a digital-asset treasury focused on decentralized artificial intelligence and distributes pharmaceutical products to international markets.

How Do They Make Money?

Pharmaceutical customers pay for products when they ship or are delivered, generally within 0 to 30 days and sometimes up to two months.

FY2025 revenue

Who Are Their Customers?

Phatebo distributes pharmaceutical products internationally, primarily in Europe, with sales also to Asia, Latin America, and North America.

Do Revenues Turn Into Profits?

No. It lost $119.7M in FY2025.

Operating income, FY2025

−433% of revenue

▲ +1633% (Loss) vs FY2024 (−$8.9M, −25%)

Net income, FY2025

−336% of revenue

▲ +652% (Loss) vs FY2024 (−$15.9M, −44%)

Free cash flow, FY2025

−25% of revenue

▲ +70% (Loss) vs FY2024 (−$5.2M, −14%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▲ +41%; vs $9.7M in Q2 FY2025
Net income: ▲ +921% (Loss); vs −$2.4M in Q2 FY2025

Aug 19, 2026 Acquired MemeCore tokens in exchange for shares and warrants It acquired 925,925,926 MemeCore tokens, valued at approximately $1 billion, in exchange for shares and warrants.
Jul 23, 2026 Completed an acquisition of 0G tokens through a share exchange Investors contributed 142,232,948 0G tokens, which ZeroStack acquired through its wholly owned Texas Blocker subsidiary.

Growing. Revenue grew 4.0x in 4 years, from $9M in FY2021 to $35.7M in FY2025, about 41% a year.

From cannabis to digital assets The older report described cannabis products, cultivation and medicinal cannabis distribution alongside pharmaceuticals. The latest report centers on a digital-asset treasury and artificial-intelligence investment, retains pharmaceutical distribution, and reports the transfer of its legacy hemp and cannabis businesses.

Comments